These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 389157)
1. Australian evaluation of Autobac I with suggested interpretive and technical modifications. Funnell GR; Guinness MD Antimicrob Agents Chemother; 1979 Sep; 16(3):255-61. PubMed ID: 389157 [TBL] [Abstract][Full Text] [Related]
2. Methicillin-resistant Staphylococcus aureus susceptibility testing by an automated system, Autobac I. Cleary TJ; Maurer D Antimicrob Agents Chemother; 1978 May; 13(5):837-41. PubMed ID: 248270 [TBL] [Abstract][Full Text] [Related]
3. Two-hospital study of Staphylococcus aureus susceptibility to penicillin and ampicillin by Autobac I. Harris PC; Sealey LB Antimicrob Agents Chemother; 1980 Dec; 18(6):922-5. PubMed ID: 7235678 [TBL] [Abstract][Full Text] [Related]
4. In vitro activity of cephalothin and three penicillins against Escherichia coli and Proteus species. Barry AL; Hoeprich PD Antimicrob Agents Chemother; 1973 Sep; 4(3):354-60. PubMed ID: 4202343 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of 500 gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agents. Rittenhouse SF; Miller LA; Utrup LJ; Poupard JA Diagn Microbiol Infect Dis; 1996 Sep; 26(1):1-6. PubMed ID: 8950521 [TBL] [Abstract][Full Text] [Related]
6. Bacterial isolation and antibiotic susceptibility from diabetic foot ulcers in Kenya using microbiological tests and comparison with RT-PCR in detection of S. aureus and MRSA. Mutonga DM; Mureithi MW; Ngugi NN; Otieno FCF BMC Res Notes; 2019 Apr; 12(1):244. PubMed ID: 31036061 [TBL] [Abstract][Full Text] [Related]
7. Autobac susceptibility testing of methicillin-resistant Staphylococcus aureus isolated in an Australian hospital. Putland RA; Guinness MD J Clin Microbiol; 1985 Nov; 22(5):822-7. PubMed ID: 3850902 [TBL] [Abstract][Full Text] [Related]
8. [Susceptibility testing with the autobac system (author's transl)]. Baars B; Opferkuch W Immun Infekt; 1978 Dec; 6(6):270-3. PubMed ID: 103806 [TBL] [Abstract][Full Text] [Related]
9. Bacterial profile and antibacterial susceptibility of otitis media among pediatric patients in Hawassa, Southern Ethiopia: cross-sectional study. Tadesse B; Shimelis T; Worku M BMC Pediatr; 2019 Nov; 19(1):398. PubMed ID: 31672140 [TBL] [Abstract][Full Text] [Related]
10. Rate of penicillin killing of Staphylococcus aureus and Autobac 1 susceptibility test results. Harris JA; Furtado D J Clin Microbiol; 1982 Feb; 15(2):270-4. PubMed ID: 7068821 [TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of bovine mastitis pathogens to a combination of penicillin and framycetin: development of interpretive criteria for testing by broth microdilution and disk diffusion. Pillar CM; Stoneburner A; Shinabarger DL; Abbeloos E; Goby L; Bradley AJ J Dairy Sci; 2014 Oct; 97(10):6594-607. PubMed ID: 25129497 [TBL] [Abstract][Full Text] [Related]
12. A comparison of the in vitro activity of tobramycin and gentamicin against 6,042 clinical isolates. Melby K; Midtvedt T; Dahl O Chemotherapy; 1979; 25(5):286-95. PubMed ID: 113179 [TBL] [Abstract][Full Text] [Related]
13. The CDS disc method of antibiotic sensitivity testing (calibrated dichotomous sensitivity test). Bell SM Pathology; 1975 Oct; 7(4 Suppl):Suppl 1-48. PubMed ID: 772573 [No Abstract] [Full Text] [Related]
14. [Probability of resistance to 10 standard- and 7 recently introduced antimicrobics in multiresistant strains of Escherichia coli, Proteus mirabilis and klebsiella spec (author's transl)]. Schröter G; Hümpfner A Zentralbl Bakteriol Orig A; 1979 Mar; 243(1):31-42. PubMed ID: 375624 [No Abstract] [Full Text] [Related]
15. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1997). I. Susceptibility distribution]. Kumamoto Y; Tsukamoto T; Hirose T; Yokoo A; Fujime M; Fujita K; Shigeta S; Watanabe J; Igari J; Ogiwara M; Ishibashi K; Oguri T; Yoshida H; Imafuku Y; Yamaguchi K; Matsumoto T; Kashitani F; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Mochida C Jpn J Antibiot; 1999 Feb; 52(2):93-129. PubMed ID: 10221177 [TBL] [Abstract][Full Text] [Related]
16. [Hospital and district differences in susceptibilities to antibiotics of main clinical isolates]. Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y; Suzuki A; Kudo H; Hayasaka N; Toyoshima S; Yamazaki Y Jpn J Antibiot; 1990 Feb; 43(2):362-73. PubMed ID: 2194057 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of cefamandole susceptibility testing of Enterobacteriacea by the autobac 1 system. de Girolami PC; Maher LA; Booth MT; St George DM J Clin Microbiol; 1980 Oct; 12(4):546-9. PubMed ID: 6999021 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial activity of erythromycin and clarithromycin against clinical isolates of Escherichia coli, Staphylococcus aureus, Klebsiella and Proteus by disc diffusion method. Khan NW; Hassan F; Naqvi BS; Hasan SM Pak J Pharm Sci; 2011 Jan; 24(1):25-9. PubMed ID: 21190914 [TBL] [Abstract][Full Text] [Related]
20. [New development on the field of antibiotic therapy]. Naumann P Internist (Berl); 1975 Sep; 16(9):407-15. PubMed ID: 810448 [No Abstract] [Full Text] [Related] [Next] [New Search]